Vanguard Personalized Indexing Management, LLC

Position in ROIV — Roivant Sciences Ltd.

CIK 1767306 OAKLAND, CA

Position in ROIV

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,853,657

+$527,492 QoQ

Shares Held

52,378

+9.4% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#202

of 494 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 64% Shared 0% None 36%

Healthcare · as of Jun 30, 2026

Vanguard Personalized Indexing Management, LLC holds $97,369,187 across 138 Biotechnology names. ROIV ranks #11 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	43,151	$21,434,396
2	REGN	Regeneron Pharmaceuticals, Inc.	11,712	$7,302,900
3	INCY	Incyte Corp	34,556	$3,917,268
4	ARGX	Argenx SE	4,103	$3,806,640
5	ALNY	Alnylam Pharmaceuticals, Inc.	11,436	$3,442,579
6	RVMD	Revolution Medicines, Inc.	17,697	$3,314,294
7	MRNA	Moderna, Inc.	43,679	$3,058,840
8	HALO	Halozyme Therapeutics, Inc.	30,414	$2,380,503

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,853,657	52,378	+9.4%	Shares	Sole	2026-08-11
2026-03-31	$1,326,165	47,876	+6.5%	Shares	Sole	2026-05-14
2025-12-31	$975,545	44,956	+3.1%	Shares	Sole	2026-02-13
2025-09-30	$659,879	43,614	+0.0%	Shares	Sole	2025-10-31
2025-06-30	$491,507	43,612	+28.0%	Shares	Sole	2025-07-25
2025-03-31	$343,705	34,064	+9.1%	Shares	Sole	2025-05-14
2024-12-31	$369,403	31,226	-19.3%	Shares	Sole	2025-02-10
2024-09-30	$446,586	38,699	+42.7%	Shares	Sole	2024-11-12
2024-06-30	$286,679	27,122	+34.3%	Shares	Sole	2024-08-12
2024-03-31	$212,844	20,194	+7.7%	Shares	Sole	2024-05-09
2023-12-31	$210,472	18,742	+26.7%	Shares	Sole	2024-02-08
2023-09-30	$172,712	14,787	+0.0%	Shares	Sole	2023-11-08
2023-06-30	$149,032	14,785	+5.0%	Shares	Sole	2023-07-28
2023-03-31	$103,903	14,079	—	Shares	Sole	2023-05-10
No filing history on record for this holder in this stock.